View Older Stories View More Recent Stories
-
Corporate Capital Trust (CCT) PT Lowered to $16.61 at BMO Capital
-
Air Products & Chemicals Inc. (APD) PT Raised to $202 at BMO Capital, Remains Top Pick in Large-Cap
-
Premium Brands Holdings Corporation (PRBZF) Target Lowered at BMO Capital
-
Sysco (SYY) PT Raised to $81 at BMO Capital
-
Switch Inc. (SWCH) PT Lowered to $14 at BMO Capital
-
General Moly Reports Second Quarter Results
-
First Data (FDC) Prices 64M Class A Share Secondary Offering at $23.75/Sh
-
BMO Capital Starts Replimune Group (REPL) at Outperform
-
First Data Announces Pricing of Secondary Offering of 64,000,000 Shares of Class A Common Stock
-
GrafTech Announces the Closing of Its Secondary Offering and Concurrent Share Buyback
-
Graybar Closes $750 Million Financing Deal
-
Teck Announces the Early Results of Cash Tender Offers
-
Funko (FNKO) PT Raised to $10.50 at BMO Capital
-
Endo International plc (ENDP) PT Raised to $16 at BMO Capital
-
Endologix (ELGX) PT Lowered to $4 at BMO Capital
-
Domtar (UFS) PT Raised to $52 at BMO Capital
-
Mizuho Hires Three Senior Corporate and Investment Bankers in the Automotive, Consumer, and Energy Sectors
-
Mizuho Hires Three Senior Corporate and Investment Bankers in the Automotive, Consumer, and Energy Sectors
-
Bausch Health Companies (BHC) PT Raised to $22 at BMO Capital
-
Alnylam Pharmaceuticals (ALNY) PT Lowered to $125 at BMO Capital; Onpattro U.S. Approval Lacks Benefit From Cardiac Data
-
BMO Capital Starts Constellation Pharmaceuticals (CNST) at Outperform
-
BMO Capital Starts Central Garden & Pet Co. (CENTA) at Outperform
-
Neos Therapeutics (NEOS) PT Lowered to $8 at BMO Capital
-
Acxiom (ACXM) PT Raised to $52 at BMO Capital
-
Amneal Pharmaceuticals (AMRX) PT Raised to $20 at BMO Capital
-
IAC/InterActiveCorp (IAC) PT Raised to $250 at BMO Capital
-
FS/KKR Advisor Announces the Closing of a New Five-Year, $3.435 Billion Revolving Credit Facility
-
Form 13F-NT BMO CAPITAL MARKETS CORP For: Jun 30
-
North American Financial 15 Split Corp. Announces Successful Overnight Offering
-
Canadian dollar to gain but needs NAFTA deal to score home run: Reuters Poll
-
Nevsun's Board of Directors Rejects Lundin Mining's Hostile Bid; Offer Does Not Recognize the Value of Nevsun's Assets; Company to Proceed with Full Strategic Review
-
Affimed Therapeutics (AFMD) PT Lowered to $4 at BMO Capital
-
ObsEva (OBSV) PT Lowered to $30 at BMO Capital
-
Conduent (CNDT) PT Raised to $23 at BMO Capital
-
Mylan (MYL) PT Lowered to $47 at BMO Capital
-
Carvana (CVNA) PT Raised to $48 at BMO Capital
-
Horizon Pharma (HZNP) PT Raised to $19 at BMO Capital
-
GrafTech International Ltd. (EAF) Prices 23M Share Upsized Common Offering at $20/Sh; Announces Concurrent 11.68M Share Buyback from Brookfield Asset Management (BAM)
-
Central Garden & Pet Company (CENT) Prices 5M Class A Share Offering at $37/Sh
-
BMO Capital Downgrades RPC Inc. (RES) to Market Perform
-
GrafTech Announces the Pricing of Secondary Offering and Concurrent Share Buyback
-
Central Garden & Pet Prices Public Offering of Class A Common Stock
-
Trevali Reports Q2-2018 Financial Results
-
Match Group (MTCH) PT Raised to $52 at BMO Capital
-
North American Financial 15 Split Corp. Announces Overnight Offering
-
Core-Mark Holding (CORE) PT Raised to $30 at BMO Capital
-
Regal Beloit (RBC) PT Raised to $92 at BMO Capital
-
TriMas Corp. (TRS) PT Raised to $34 at BMO Capital
-
Kennametal (KMT) PT Raised to $46 at BMO Capital
-
Alder Biopharm (ALDR) PT Raised to $23 at BMO Capital
